Participants 23 104 5
myocardial infarction and unstable angina in patients with low ejection fractions
Participants 349 475 6
6797 patients with ejection fractions < or = 0.35 enrolled into the two Studies of Left Ventricular Dysfunction (SOLVD) trials
Participants 647 785 5
Patients with heart failure entered the treatment trial (n = 2569) and those without heart failure entered the prevention trial (n = 4228)
Participants 1107 1201 5
362 placebo group patients with myocardial infarction compared with 288 in the enalapril group
Participants 1250 1343 4
595 placebo group patients developed unstable angina compared with 499 in the enalapril group
Participants 1650 1793 5
Enalapril treatment significantly reduced myocardial infarction, unstable angina, and cardiac mortality in patients with low ejection fractions
